UROTHELIAL CARCINOMA
Clinical trials for UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced bladder cancer: SYS6002 takes on chemo in major trial
Disease control Not yet recruitingThis phase 3 trial tests a new drug called SYS6002 against standard chemotherapy for people with advanced bladder cancer that has not responded to platinum chemo and immunotherapy. About 406 adults aged 18-75 will be randomly assigned to receive either SYS6002 or a chemo chosen b…
Matched conditions: UROTHELIAL CARCINOMA
Phase: PHASE3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated May 26, 2026 06:59 UTC
-
New hope for bladder cancer: maintenance drug after chemo aims to keep tumors at bay
Disease control Not yet recruitingThis study tests whether the drug avelumab can help people with advanced bladder cancer that has spread (metastatic urothelial carcinoma) live longer without their cancer getting worse. Participants will have already received two prior treatments, including chemotherapy, and then…
Matched conditions: UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica • Aim: Disease control
Last updated May 26, 2026 06:47 UTC
-
Massive bladder cancer study to reveal Real-World treatment outcomes
Knowledge-focused Not yet recruitingThis study will look at medical records from 3,000 adults with advanced bladder cancer to see how long their first treatment keeps the disease from getting worse. Researchers will also track which medicines doctors actually prescribe. This is not a new treatment trial—it simply o…
Matched conditions: UROTHELIAL CARCINOMA
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC